Therapeutics Company Secures Positive Opinion For AMD Treatment

A New Dawn in Treating Wet Age-Related Macular Degeneration: The Groundbreaking Approval of ONS-5010.

As an investor it's important to stay updated with major news. Get real-time stock market alerts, news, and research by creating an account here.

In an era where medical advancements are pivotal to enhancing quality of life, a significant breakthrough has been made in the treatment of wet age-related macular degeneration (AMD), a leading cause of vision …